Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane

British Journal of Cancer

Volumn 68, Issue 5, 1993, Pages 932-938

  Danesi, R ^a   Del Bianchi, S ^b   Soldani, P ^c   Campagni, A ^b   La Rocca, R V ^d   Myers, C E ^d   Paparelli, A ^c   Del Tacca, M ^e  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

^b Centro Ricerche Esperienze Studi Applicazioni Militari ^*  (Italy)

^c Istituto di Anatomia Umana Normale   (Italy)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BASIC FIBROBLAST GROWTH FACTOR; HEPARIN; HYDROCORTISONE; SURAMIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; CATTLE; CELL GROWTH; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIS; DNA SYNTHESIS; EMBRYO; ENDOTHELIUM CELL; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL;

ALLANTOIS; ANIMAL; CATTLE; CELL DIVISION; CELLS, CULTURED; CHICK EMBRYO; CHORION; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; HEPARIN; HUMAN; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDES, ANTISENSE; SUPPORT, NON-U.S. GOV'T; SURAMIN;

EID: 0027489946     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1993.457     Document Type: Article

References (40)

1. ABRAHAM, J.A., MERGIA, A., WHANG, J.L., TUMOLO, A., FRIEDMAN, J., HJERRILD, K.A., GOSPODAROWICZ, D. & FIDDES, J.C. (1986). Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science, 233, 545-548.
2. BALDIN, V., ROMAN, A. M., BOSC-BIERNE, I., AMALRIC, F. & BOUCHE, G. (1990). Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J., 9, 1511-1517.
3. BECKER, D., MEIER, C.B. & HERLYN, M. (1989). Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J., 8, 3685-3691.
4. COFFEY, R.J. Jr, LEOF, E.B., SHIPLEY, G.D. & MOSES, H.L. (1987). Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J. Cell. Physiol., 132, 143-148.
5. DOBSON, D.E., KAMBE, A., BLOCK, E., DION, T., LU, H., CASTELLOT, J.J. Jr. & SPIEGELMAN, B.M. (1990). 1-Butyryl-glycerol: a novel angiogenesis factor secreted by differentiating adipocytes. Cell, 61, 223-230.
6. DUNN, B.E., FITZHARRIS, T.P. & BARNETT, B.D. (1981). Effects of varying chamber construction and embryo pre-incubation age on survival and growth of chick embryos in shell-less culture. Anat. Rec., 199, 33-43.
7. FOLKMAN, J., LANGER, R., LINHARDT, R.J., HAUDENSCHILD, C. & TAYLOR, S. (1983). Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science, 111, 719-725.
8. FOLKMAN, J. (1990). What is the evidence that tumours are angiogenesis-dependent? J. Natl Cancer Inst., 82, 4-6.
9. GAGLIARDI, A. & COLLINS, D.C. (1993). Inhibition of angiogenesis by antiestrogens. Cancer Res., 53, 533-535.
10. GOSPODAROWICZ, D., MORAN, J., BRAUN, D. & BIRDWELL, C. (1976). Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent. Proc. Natl Acad. Sci. USA, 73, 4120-4124.
11. HAWKING, F. (1978). Suramin: with special reference to onchocerciasis. Adv. Pharmacol. Chemother., 15, 289-322.
12. HAYEK, A., CULLER, F.L., BEATTIE, G.M., LOPEZ, A.D., CUEVAS, P. & BAIRD, A. (1987). An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. Biochem. Biophys. Res. Commun., 147, 876-880.
13. HELENE, C. & TOULME, J.-J. (1990). Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim. Biophys. Acta, 1049, 99-125.
14. HORI, A., SASADA, R., MATSUTANI, E., NAITO, K., SAKURA, Y., FUJITA, T. & KAZAI, Y. (1991). Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res., 51, 6180-6184.
15. INGBER, D., FUJITA, T., KISHIMOTO, S., SUDO, K., KANAMARU, T., BREM, H. & FOLKMAN, J. (1990). Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature, 348, 555-557.
16. KHAN, M.Y. & NEWMAN, S.A. (1990). An assay for heparin by decrease in color yield (DECOY) of a protein-dye-binding reaction. Anal. Biochem., 187, 124-128.
17. LA ROCCA, R.V., STEIN, C.A., DANESI, R., MYERS, C.E. (1990). Suramin, a novel antitumour compound. J. Steroid Biochem. Mol. Biol., 37, 893-898.
18. LEE, J.K., CHOI, B., SOBEL, R.A., CHIOCCA, E.A. & MARTUZA, R.L. (1990). Inhibition of growth and angiogenesis of human neurofibrosarcoma by heparin and hydrocortisone. J. Neurosurg., 73, 429-435.
19. MAIONE, T.E. & SHARPE, R.J. (1990). Development of angiogenesis inhibitors for clinical applications. Trends Pharmacol. Sci., 11, 457-461.
20. MARAGOUDAKIS, M E., SARMONIKA, M. & PANOUTSACOPOULOU, M. (1989). Angiogenic action of heparin plus cortisone is associated with decreased collagenous protein synthesis in the chick chorioallantoic membrane system. J. Pharmacol. Exp. Ther., 251, 679-682.
21. MIGNATTI, P. & RIFKIN, D.B. (1991). Release of basic fibroblast growth factor, an angiogenic factor devoided of secretory signal sequence -a trivial phenomenon or a novel secretion mechanism. J. Cell. Biochem., 47, 201-207.
22. MOSCATELLI, D. & QUARTO, N. (1989). Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of the receptor number by suramin. J. Cell. Biol., 109, 2519-2527.
23. MYERS, C., COOPER, M., STEIN, C., LA ROCCA, R., MCCLELLAN, M.W., WEISS, G., CHOYKE, P., DAWSON, N., STEINBERG, S., UHRICH, M.M., CASSIDY, J., KOHLER, DR., TREPEL, J. & LINEHAN, M.W. (1992). Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer. J. Clin. Oncol., 10, 881-889.
24. NAKAMOTO, T., CHANG, C., LI, A. & CHODAK, G.W. (1992). Basic fibroblast growth factor in human prostate cancer cells. Cancer Res., 52, 571-577.
25. PONTZER, C.H., BAZER, F.W. & JOHNSON, H.M. (1991). Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1. Cancer Res., 51, 5304-5307.
26. PROIA, A.D., CHANDLER, D.B., HAYNES, W.L., SMITH, C.F., SUVARNAMANI, C., ERKEL, F.H. & KLINTWORTH, G.K. (1988). Quantitation of corneal neovascularization using computerized image analysis. Lab. Invest., 58, 473-479.
27. RISAU, W. (1990). Angiogenic growth factors. Progr. Growth Factor Res., 2, 71-79.
28. SAMBROOK, J., FRITSCH, E.F. & MANIATIS, T. (1989). Molcular Coning -A Laboratory Manual. 2nd Edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor.
29. SATO, Y. & RIFKIN, D.B. (1988). Autocrine effect of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J. Cell. Biol., 107, 1199-1205.
30. SCHIEBINGER, R.J., CHROUSOS, G.P., CUTLER, G.B. Jr & LORIAUX D.L. (1986). The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects. J. Clin. Endrocrinol. Metab., 62, 202-209.
31. SCHREIBER, A.B., WRINKLER, M E., DERYNCK, R. (1986). Transforming growth factor-a; a more potent angiogenic mediator than epidermal growth factor. Science, 233, 1250-1253.
32. STEIN, C.A., LA ROCCA, R.V., THOMAS, R., McATEE, N. & MYERS, C.E. (1989). Suramin: an anticancer drug with a unique mechanism of action. J. Clin. Oncol., 7, 499-508.
33. SUPKO, J.G. & MALSPEIS, L. (1990). A rapid isocratic HPLC assay of suramin (NSC 34936) in human plasma. J. Liquid Chromatogr., 13, 727-741.
34. VU, M.T., SMITH, C.F., BURGER, P.C. & KLINTWORTH, G.K. (1985). An evaluation of methods to quantitate the chick chorioallantoic membrane assay in angiogenesis. Lab. Invest., 53, 499-508.
35. WEIDNER, N., SEMPLE, J.P., WELCH, W.R. & FOLKMAN, J. (1991). Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma. N. Engl. J. Med., 324, 1-8.
36. WILKS, J.W., SCOTT, P.S., VRBA, L.K. & COCUZZA, J.M. (1991). Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin. Int. J. Radiat. Biol., 60, 73-77.
37. WISEMAN, D M., POLVERINI, P.J., KAMP, D.W. & LEIBOWICH, S.J. (1988). Transforming growth factor P (TGF-p) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem. Biophys. Res. Commun., 157, 793-800.
38. WOLTERING, E.A., BARRIE, R., O’DORISIO, T.M., ARCE, D., URE, T., CRAMER, A., HOLMES, D., ROBERTSON, J. & FASSLER, J. (1991). Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. J. Surg. Res., 50, 245-251.
39. YAYON, A. & KLAGSBRUN, M. (1990). Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin. Proc. Natl Acad. Sci. USA, 87, 5346-5350.
40. ZAR, J.H. (1984). Biostatistical Analysis. Prentice-Hall: Englewood Cliffs.